Your browser doesn't support javascript.
loading
Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.
Islam, Mohamed Shariful; Hassan, Zarih Alcheikh; Chalmin, Florence; Vido, Sandor; Berrada, Mohamed; Verhelst, David; Donnadieu, Patrick; Moranne, Olivier; Esnault, Vincent L M.
Afiliação
  • Islam MS; Nephrology Department, Pasteur University Hospital of Nice, Nice, France. Electronic address: islam.ms@chu-nice.fr.
  • Hassan ZA; Nephrology Department, General Hospital of Avignon, Avignon, France.
  • Chalmin F; Nephrology Department, Pasteur University Hospital of Nice, Nice, France.
  • Vido S; Nephrology Department, Pasteur University Hospital of Nice, Nice, France.
  • Berrada M; Nephrology Department, Pasteur University Hospital of Nice, Nice, France.
  • Verhelst D; Nephrology Department, General Hospital of Avignon, Avignon, France.
  • Donnadieu P; Nephrology Department, General Hospital of Avignon, Avignon, France.
  • Moranne O; Nephrology Department, Pasteur University Hospital of Nice, Nice, France.
  • Esnault VL; Nephrology Department, Pasteur University Hospital of Nice, Nice, France; Nice Sophia-Antipolis University, Nice, France.
Am J Kidney Dis ; 68(5): 752-762, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27344212
BACKGROUND: Hemodialysis requires effective anticoagulation to avoid blood circuit clotting. In patients at high risk for bleeding, several alternative methods have been developed. STUDY DESIGN: Multicenter, prospective, randomized, crossover study evaluating the noninferiority of vitamin E-coated compared with heparin-coated dialyzers in a 4-hour heparin-free hemodialysis strategy. SETTINGS & PARTICIPANTS: 32 adult long-term hemodialysis patients from 2 French hemodialysis units with well-functioning fistulas or double-lumen catheters. INTERVENTION: Patients were randomly allocated to a first period using either vitamin E- or heparin-coated dialyzers. After a washout period of 2 hemodialysis sessions, each patient was switched to the alternative dialyzer for a second period. Each study period started with 2 hemodialysis sessions with reduced heparin dose (50% and 25% of usual heparin dose, respectively, for sessions 1 and 2) followed by 2 heparin-free sessions. OUTCOMES: The primary end point was the percentage of successful study periods, defined as no circuit-clotting event leading to premature interruption of any of the 4 dialysis sessions. Secondary end points included total number and cumulative duration of hemodialysis sessions without clotting, number of saline solution flushes, dialysis circuit bubble trap status and dialyzer membrane status by visual inspection, and dialysis adequacy. RESULTS: The percentage of success with vitamin E-coated dialyzers (25/32 study periods [78%]) was not inferior to that with heparin-coated dialyzers (26/32 study periods [81%]). Visual inspection showed equal numbers of clean dialysis circuit bubble traps (vitamin E-coated, 34/121; heparin-coated, 32/120), whereas clean fiber bundles were more frequently noted with the vitamin E-coated compared with heparin-coated dialyzers (25/121 vs 2/120; P=0.002). LIMITATIONS: Results may not extrapolate to critically ill patients. Differences in dialyzer transparency may account for visual inspection scores. CONCLUSIONS: The success rate of 4-hour heparin-free hemodialysis sessions is lower than that previously claimed in uncontrolled studies. Vitamin E-coated and heparin-coated dialyzers exposed patients to similar and unacceptable high failure rates. Further studies are required to improve heparin-free hemodialysis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitamina E / Heparina / Diálise Renal / Membranas Artificiais / Anticoagulantes / Antioxidantes Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitamina E / Heparina / Diálise Renal / Membranas Artificiais / Anticoagulantes / Antioxidantes Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article